CNTB: Connect Biopharma Holdings Limited - American Depositary Shares

2.10 USD 0.26 (14.13%)

Sector: Atención Sanitaria Básica: US Dollar Divisa de beneficio: US Dollar

El tipo de cambio de CNTB de hoy ha cambiado un 14.13%. En este caso, el precio mínimo en el mercado ha alcanzado 1.73, mientras que el máximo ha alcanzado 2.11.

Siga la dinámica de la pareja de divisas Connect Biopharma Holdings Limited - American Depositary Shares. El gráfico histórico le mostrará cómo ha cambiado el precio de %AssetName% en el pasado. Alternando entre diferentes marcos temporales, podrá monitorear las tendencias y la dinámica del tipo de cambio por minutos, horas, días, semanas y meses. Use esta información para predecir los cambios en el mercado y tomar decisiones comerciales fundamentadas.

Gráfico a pantalla completa

CNTB News

Zacks 16:00 What Makes Connect Biopharma Holdings Limited Sponsored ADR (CNTB) a Strong Momentum Stock: Buy Now?
Investing 13:45 Connect Biopharma stock rating reiterated as Outperform by Northland
Investing 13:32 Connect Biopharma appoints Jim Schoeneck to board of directors
Investing 13:17 Connect Biopharma appoints James A. Schoeneck to board of directors
Investing 13:52 Connect Biopharma stock rises after announcing plan to terminate ADR program
Investing 13:16 Connect Biopharma to terminate ADR program, list ordinary shares
Investing 13:31 Connect Biopharma regains Nasdaq compliance with minimum bid price rule
Investing 13:07 Connect Biopharma regains Nasdaq compliance with $1 minimum bid price
Investing 13:13 Connect Biopharma’s partner submits new drug application in China
Investing 13:05 Connect Biopharma reports positive data for asthma treatment
Investing 13:52 Connect Biopharma Announces Two Oral Presentations at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress
Investing 13:40 Connect Biopharma to Present at Two Upcoming Investor Conferences in June
Investing 13:32 Connect Biopharma Presents Data Supporting Development of Rademikibart at the American Thoracic Society (ATS) 2025 International Conference
Investing 13:52 Connect Biopharma Reports First Quarter 2025 Financial Results and Provides Business Update
Investing 13:27 Connect Biopharma Initiates Phase 2 Seabreeze STAT COPD Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in COPD

Rango diario

1.73 2.11

Rango anual

0.51 2.86

Cierres anteriores: 1.75
Open: 1.84

Bid: 2.10
Ask: 2.40

Low: 1.73
High: 2.11

Volumen: 450

Cambio diario: 14.13%
Cambio mensual: 101.92%

Cambio a 6 meses: 116.49%
Cambio anual: 77.97%

31 julio, jueves